Money News

Money News

Money News — the most respected business program on radio.

If you crave the latest insights into super & small business, interest rates & investment, and economics & e-commerce, then the team at Money News has everything you need to know.

Add your voice to the conversation Monday to Thursday 7pm to 8pm by calling 131 873, texting 0460 873 873, or emailing moneynews@2gb.com

00:00
00:00

Episodens resumé

This is your week in Money News, with Clinton Maynard. Heather Macilvane on David Jones John McGrath on Real Estate Catherine King on Career Coach Roger Montgomery on Productivity Jane Hume on Red Tape Joel Harty on ETFs Michael Brennan on Bracket Creep See omnystudio.com/listener for privacy information.

Episoder

11472-

MONEY WEEK with Clinton Maynard - Friday 13 November

This is your week in Money News, with Clinton Maynard. Heather Macilvane on David Jones John McGrath on Real Estate Catherine King on Career Coach Roger Montgomery on Productivity Jane Hume on Red Tape Joel Harty on ETFs Michael Brennan on Bracket Creep See omnystudio.com/listener for privacy information.

12 nov. 2026
11471-

Will Biotech Research go Offshore?

This episode features an interview with AusBiotech CEO Rebecca Cassidy regarding proposed changes to Australia's Research and Development Tax Incentive. The discussion focuses on a proposed 15-year cap on these incentives, which industry representatives argue fails to account for the lengthy timelines required for complex clinical trials in areas such as oncology and dementia. Cassidy highlights the risk of pushing advanced manufacturing and late-stage research offshore, potentially undermining the Australian biotech sector's ability to retain high-value jobs and medical innovation. The conversation explores the economic implications for companies that have invested decades into domestic research and the potential loss of clinical trial participation for Australians.

12 nov. 2026
11470-

Can we really improve productivity?

In this episode, host Clinton interviews funds manager Roger Montgomery to explore the implications of Australia's declining productivity. The discussion examines how productivity serves as a measure of economic efficiency and its direct link to the standard of living, inflation, and interest rates. Montgomery argues that recent declines in labor and multi-factor productivity are tied to government policy, specifically regarding tax settings and workplace laws. The conversation further critiques a recent inquiry commissioned by Treasurer Jim Chalmers, which Montgomery claims avoids investigating the very tax and regulatory barriers that hinder business growth. The episode concludes with a discussion on the need for radical 'break glass' reforms to the tax code to prevent long-term economic stagnation.

12 nov. 2026
11469-

Investing in AI

This episode explores how Australian investors can gain exposure to the artificial intelligence sector through various platforms and international markets. Featuring John Winters, co-founder of the investing platform Superhero, the discussion covers the high demand for AI investments, the accessibility of major US IPOs like Anthropic, and the current volatility surrounding NVIDIA. The conversation also touches upon the role of information accessibility in modern trading and the potential long-term growth prospects of AI-related stocks despite recent market fluctuations.

12 nov. 2026
11468-

Money News with Clinton Maynard 💵 - Wednesday, 12th November

This episode of Money News explores a range of economic and corporate developments, beginning with concerns over Australia's declining productivity and the potential for increased sick leave surrounding the Grand Theft Auto release. The program also covers significant banking news, including NAB's massive staff underpayment settlement and ASIC's lawsuit against CBA regarding business fees. The discussion extends to the impact of NVIDIA's leadership situation on Australian superannuation funds and the financial implications of EV tax breaks in Australia. Additionally, the episode examines the risks that R&D tax incentive caps pose to the biotech sector and provides updates on bank CEOs testifying before a parliamentary inquiry.

12 nov. 2026